Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Average Rating of “Hold” by Brokerages
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have received a consensus recommendation of “Hold” from the nineteen ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the […]
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have received a consensus recommendation of “Hold” from the nineteen ratings firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the […]
